SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (29357)11/5/1999 3:28:00 PM
From: SPSEIFERT  Respond to of 32384
 
Henry Cell Pathways is presenting to the FDA on the same day as Ligand. I have heard that there is a strong likelihood that they will be approved on Apostyn for polyps treatment and that there is evidence that it will be used offlabel for a variety of cancers if approved. Can you respond to the potential if you're familiar with the Co.? Thx